Abstract:Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with clinical characterized by short course, rapid progression and rapid deterioration. At present, the studies on the regulatory factors of PDAC are not enough.Methods: In this study, we applied transcriptome sequencing with PDAC tumor and normal tissues (5cases). Expression of miR-199a-5p was detected by qPCR in another 10 pairs of cancer and normal tissues. The miR-199a-5p mimic, miR-199a-5p mimic NC, miR-199a-5p inhibitor, and miR-199a-5p inhibitor NC were used to detect the function of miR-199a-5p in cell lines. Construction of double luciferase reporter vector of VASH1-AS1 and PDCD4 were used to confirm the binding of miR-199a-5p and 3’- UTR of human PDCD4 mRNA and VASH1-AS1, respectively. PDCD4 protein expression was detected by Western Blot. The cell apoptosis assay was performed using the Annexin V-FITC Kit. Cell proliferation was detected using CCK-8assay and EdU fluorescence analysis. Cell cycle and apoptosis analyzed by flow cytometry at excitation and emission wavelengths of 488 and 530 nm, respectively. SPSS software (version 22.0; SPSS, Chicago, USA) and GraphPad Prism 5.0 (GraphPad software, San Diego, California, USA) were used for data analysis.Results: After data preprocessing, differentially expressed lncRNAs (606 up-regulated, 875 down-regulated), miRNAs (171 up-regulated, 188 down-regulated) and genes (4129 up-regulated, 3417 down-regulated) were identified. With dada analysis, a new VASH1-AS1/miR-199a-5p/PDCD4 regulation mode was discovered. In PDAC, the expression level of miR-199a-5p is negatively correlated with VASH1-AS1, and the further binding was performed between miR-199a-5p and PDCD4. The overexpression of miR-199a-5p can promote the proliferation and cycle of tumor cells, inhibit cell apoptosis. If the expression of miR-199a-5p is inhibited, the opposite result was obtained. By using overexpression vectors and siRNA of PDCD4, we also found that the low expression of PDCD4 can promote tumor cell proliferation and cycle, and inhibit cell apoptosis. If PDCD4 is highly expressed, the opposite result is obtained.. Conclusion: These findings suggest that lncRNA VASH1-AS1/miR-199a-5p/PDCD4 axis may regulate the formation of PDAC through synergy, and show potential application as an early diagnostic and prognostic marker for PDAC.

Overexpression of Mir-135b-5p Promotes Unfavorable Clinical Characteristics and Poor Prognosis Via the Repression of Sfrp4 in Pancreatic Cancer

lncRNA VASH1-AS1/miR-199a-5p/PDCD4 Axis Regulate Proliferation, Apoptosis, and Cell Cycle in PDAC Progress

Long Non-Coding RNA DSCAM-AS1 Promotes Pancreatic Cancer Progression Via Regulating the Mir-136-5p/pbx3 Axis

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

MicroRNA-301a-3p Promotes Pancreatic Cancer Progression Via Negative Regulation Ofsmad4

Overexpressions of Mir-212 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

MiR-139-5p/SLC7A11 Inhibits the Proliferation and Migration of Pancreatic Carcinoma via PI3K/Akt Signaling Pathway

The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.

MiR-135b-5p is an Oncogene in Pancreatic Cancer to Regulate GPRC5A Expression by Targeting Transcription Factor KLF4

miR-497-5p Inhibits Proliferation of Pancreatic Cancer Cells by Targeting CCNE1 Gene

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

LINC00460 Promotes Pancreatic Cancer Progression by Sponging Mir‐491‐5p

MicroRNA-135a Inhibits Cell Proliferation by Targeting Bmi1 in Pancreatic Ductal Adenocarcinoma

Microrna-148a-3p Suppresses Epithelial-To-Mesenchymal Transition And Stemness Properties Via Wnt1-Mediated Wnt/Beta-Catenin Pathway In Pancreatic Cancer

MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway

Mir-133A Functions As a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer.

Mir-615-5p is Epigenetically Inactivated and Functions As a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma

miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer

MicroRNA-506 is Up-Regulated in the Development of Pancreatic Ductal Adenocarcinoma and is Associated with Attenuated Disease Progression

MiR-744 Increases Tumorigenicity of Pancreatic Cancer by Activating Wnt/β-catenin Pathway

Upregulated Mir-27A-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway.